Regulation of MicroRNA-155 in Atherosclerotic Inflammatory Responses by Targeting MAP3K10

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zhu, Jianhua ^a   Chen, Ting ^a   Yang, Lin ^a   Li, Zhoubin ^a   Wong, Mei Mei ^b   Zheng, Xiaoye ^a   Pan, Xiaoping ^a   Zhang, Li ^a   Yan, Hui ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CELL PROTEIN; MICRORNA 155; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 10; TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; GENE CONTROL; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; THORACIC AORTA; TRANSCRIPTION REGULATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MICRORNAS; PLAQUE, ATHEROSCLEROTIC;

MUS;

EID: 84870046720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046551     Document Type: Article

References (36)

1. Hansson GK, (2005) Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 352: 1685-1695.
2. Hansson GK, Libby P, (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6: 508-519.
3. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 16: 281-297.
4. van Rooij E, Olson EN, (2007) MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117 (9) (): 2369-2376.
5. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M, (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
6. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, et al. (2007) MicroRNAs in the human heart. A clue to fetal gene reprogramming in heart failure. Circulation 116: 258-267.
7. Ikeda S, Kong SK, Lu J, Bisping E, Zhang H, et al. (2007) Pu. Altered microRNA expression in human heart disease. Physiol Genomics 31: 367-373.
8. Faraoni I, Antonetti FR, Cardone J, Bonmassar E, (2009) miR-155 gene: A typical multifunctional microRNA. Biochimica et Biophysica Acta 1792: 497-505.
9. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104 (5) (): 1604-9.
10. Chen T, Huang Z, Wang L, Wang Y, Wu F, et al. (2009) MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 83: 131-139.
11. Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, et al. (2010) Induction of microRNAs, miR-155, miR-222, miR-424 and miR-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24 (2) (): 460-6.
12. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, et al. (2006) MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol Jul;9 (7) (): 775-87.
13. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappaB-dependent induction of miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486.
14. Mi S, Li Z, Chen P, He C, Cao D, Elkahloun A, et al. (2010) Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci U S A 107 (8) (): 3710-5.
15. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131 (1) (): 146-59.
16. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451 (7182) (): 1125-9.
17. Chen T, Li Z, Tu J, Zhu W, Ge J, et al. (2011) MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Letters 585: 567-573.
18. Chen T, Yan H, Li Z, Zhu W, Ge J, et al. (2011) MicroRNA-155 regulates lipid uptake, adhesion/chemokine marker secretion and SCG2 expression in oxLDL-stimulated dendritic cells/macrophages. Int J Cardiol 17; 147 (3) (): 446-7.
19. Chen T, Li Z, Tu J, Zhu W, Ge J, et al. (2011) MicroRNA-29a regulates pro-inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL-stimulated dendritic cells. FEBS Letters 585: 657-663.
20. Ceppia M, Pereirad PM, Dunand-Sauthierf I, le Barrasf E, Reithf W, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. PNAS 106: 2735-2740.
21. Huang RS, Hu GQ, Lin B, Lin ZY, Sun CCJ, (2010) MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. Investig Med 58 (8) (): 961-7.
22. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating MicroRNAs in Patients With Coronary Artery Disease. Circ Res 107 (5) (): 677-84.
23. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 31: 659-666.
24. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, et al. (2010) Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 56 (7) (): 1183-5.
25. Ai J, Zhang R, Li Y, Pu J, Lu Y, (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391: 73-77.
26. Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, et al. (2010) The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 9;394 (3) (): 792-7.
27. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19 (2) (): 232-43.
28. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, et al. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (7014) (): 173-8.
29. Zhong J, Kyriakis JM, (2007) Dissection of a signaling pathway by which pathogen-associated molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine release. J Biol Chem 282: 24246-54.
30. Akbarzadeh S, Ji H, Frecklington D, Marmy-Conus N, Mok YF, et al. (2002) Mixed lineage kinase 2 interacts with clathrin and influences clathrin-coated vesicle trafficking. J Biol Chem 277: 36280-7.
31. He M, Xu Z, Ding T, Kuang DM, Zheng L, (2009) MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPB. Cell Mol Immunol 6: 343-52.
32. Ceppia M, Pereirad PM, Dunand-Sauthierf I, le Barrasf E, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. 106: 2735-2740.
33. Lu C, Huang X, Zhang X, Roensch K, Cao Q, et al. (2011) miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27 kip1, KPC1, and SOCS-1. Blood 117 (16) (): 4293-303.
34. Cardoso AL, Guedes JR, PereiradeAlmeida L, PedrosodeLima MC, (2012) miR-155 modulates microglia-mediate immune response by down-regulating SOCS-1 andpromoting cytokine and nitric oxide production. Immunology 135 (1) (): 73-88.
35. Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, et al. (2009) MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One 4 (12) (): e8508.
36. Dong C, Davis RJ, Flavell RA, (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55-72.